AVITA Medical, Inc. (RCEL) Guidance & Earnings Results

On 2026-08-06 AVITA Medical, Inc. raised guidance: "FY2026 revenue raised to $86-89M from $80-85M; Q4 2026 cash flow breakeven…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RCELAVITA Medical, Inc.Follow RCEL — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 479.7M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Aug 26	Raised	FY2026 revenue raised to $86-89M from $80-85M; Q4 2026 cash flow breakeven expected · full year
14 May 26	Reaffirmed	FY26 revenue $80-85M, representing growth of approximately 12% to 19% compared to 2025 revenue · full year
12 Feb 26	Raised	FY2026 revenue $80-85M vs FY2025 $71.6M; growth 12-19% · full year
13 Jan 26	Raised	FY2026 revenue $80-85M, representing growth of 12-19% vs FY2025 revenue of $71.6M · full year
6 Nov 25	Lowered	FY2025 revenue lowered to $70-74M from $76-81M · full year
7 Aug 25	Lowered	FY25 revenue guidance updated; revenue covenants lowered: Q3 2025 $73M, Q4 2025 $77M, Q1 2026 $90M, Q2 2026 $103M (trailing 12-month). · full year

AVITA Medical, Inc. — questions

What guidance did AVITA Medical, Inc. give?: On 2026-08-06: "FY2026 revenue raised to $86-89M from $80-85M; Q4 2026 cash flow breakeven expected"
When does AVITA Medical, Inc. report earnings?: AVITA Medical, Inc.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from AVITA Medical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.